Mari Kogiso

Children's Nutrition Research Center, Baylor College of Medicine

Affiliated withBaylor College of Medicine

Research Area

Biography

Mari Kogiso has not added Biography.
If you are Mari Kogiso and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2024

Other Publications

Article	Year
A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in children. Neuro-oncology\| PubMed ID: 24470556	2014
USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. The Journal of experimental medicine\| PubMed ID: 24493797	2014
Inhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure-activity relationship, and selective antitumor activity. Journal of medicinal chemistry\| PubMed ID: 25271760	2014
Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes. Acta neuropathologica communications\| PubMed ID: 25526772	2014
Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumors. Neuro-oncology\| PubMed ID: 25537021	2015
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nature medicine\| PubMed ID: 25939062	2015
Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds. Journal of medicinal chemistry\| PubMed ID: 26280302	2015
Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma. Journal of neuro-oncology\| PubMed ID: 26956263	2016
A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer. Oncotarget\| PubMed ID: 26967057	2016
HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma. Cancer cell\| PubMed ID: 26977882	2016
Xenotransplantation of pediatric low grade gliomas confirms the enrichment of V600E mutation and preservation of deletion in a novel orthotopic xenograft mouse model of progressive pleomor... Oncotarget\| PubMed ID: 29152094	2017
Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 29463553	2018
Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer. Medicinal chemistry (Shariqah (United Arab Emirates))\| PubMed ID: 29792149	2018
Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma. Science translational medicine\| PubMed ID: 30355798	2018
Transcriptional repressor REST drives lineage stage-specific chromatin compaction at and increases AKT activation in a mouse model of medulloblastoma. Science signaling\| PubMed ID: 30670636	2019
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma. Nature neuroscience\| PubMed ID: 32424282	2020
Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma. Cancers\| PubMed ID: 32517016	2020
Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors. Cancer letters\| PubMed ID: 32891713	2020
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma. Cancer research\| PubMed ID: 33046443	2020
Corrigendum to "Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors" [Cancer Lett. 493 (2020... Cancer letters\| PubMed ID: 33358190	2021
Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion. Advanced science (Weinheim, Baden-Wurttemberg, Germany)\| PubMed ID: 34719887	2021
Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies. Laboratory investigation; a journal of technical methods and pathology\| PubMed ID: 34802040	2022
Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma. Nature neuroscience\| PubMed ID: 34907396	2022
Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma. Translational oncology\| PubMed ID: 35182954	2022
Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 35797217	2022
Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas. Nature communications\| PubMed ID: 36335125	2022
Publisher Correction: Epigenetic alterations of repeated relapses in patient-matched childhood ependymomas. Nature communications\| PubMed ID: 36550163	2022
Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models. Journal of translational medicine\| PubMed ID: 37415222	2023